Adeno-associated virus: fit to serve
Tài liệu tham khảo
Atchison, 1965, Adenovirus-associated defective virus particles, Science, 149, 754, 10.1126/science.149.3685.754
Knipe, 2013
MacLaren, 2014, Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial, Lancet, 383, 1129, 10.1016/S0140-6736(13)62117-0
Maguire, 2008, Safety and efficacy of gene transfer for Leber's congenital amaurosis, N Engl J Med, 358, 2240, 10.1056/NEJMoa0802315
Nathwani, 2011, Adenovirus-associated virus vector-mediated gene transfer in hemophilia B, N Engl J Med, 365, 2357, 10.1056/NEJMoa1108046
Weinberg, 2013, Adeno-associated virus (AAV) gene therapy for neurological disease, Neuropharmacology, 69, 82, 10.1016/j.neuropharm.2012.03.004
Johnson, 2009, Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys, Nat Med, 15, 901, 10.1038/nm.1967
Balazs, 2012, Antibody-based protection against HIV infection by vectored immunoprophylaxis, Nature, 481, 81, 10.1038/nature10660
Balazs, 2013, Broad protection against influenza infection by vectored immunoprophylaxis in mice, Nat Biotechnol, 31, 647, 10.1038/nbt.2618
Limberis, 2013, Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza, Sci Transl Med, 5, 187ra172, 10.1126/scitranslmed.3006299
Calcedo, 2009, Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses, J Infect Dis, 199, 381, 10.1086/595830
Boutin, 2010, Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors, Hum Gene Ther, 21, 704, 10.1089/hum.2009.182
Cotmore, 2014, The family Parvoviridae, Arch Virol, 159, 1239, 10.1007/s00705-013-1914-1
Shackelton, 2005, High rate of viral evolution associated with the emergence of carnivore parvovirus, Proc Natl Acad Sci U S A, 102, 379, 10.1073/pnas.0406765102
Lopez-Bueno, 2003, High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host, J Virol, 77, 2701, 10.1128/JVI.77.4.2701-2708.2003
Shackelton, 2006, Phylogenetic evidence for the rapid evolution of human B19 erythrovirus, J Virol, 80, 3666, 10.1128/JVI.80.7.3666-3669.2006
Hueffer, 2003, The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor, J Virol, 77, 1718, 10.1128/JVI.77.3.1718-1726.2003
Stucker, 2012, The role of evolutionary intermediates in the host adaptation of canine parvovirus, J Virol, 86, 1514, 10.1128/JVI.06222-11
Allison, 2013, Frequent cross-species transmission of parvoviruses among diverse carnivore hosts, J Virol, 87, 2342, 10.1128/JVI.02428-12
Kaelber, 2012, Evolutionary reconstructions of the transferrin receptor of Caniforms supports canine parvovirus being a re-emerged and not a novel pathogen in dogs, PLoS Pathog, 8, e1002666, 10.1371/journal.ppat.1002666
Lukashov, 2001, Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses, J Virol, 75, 2729, 10.1128/JVI.75.6.2729-2740.2001
Sonntag, 2011, The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes, J Virol, 85, 12686, 10.1128/JVI.05359-11
Naumer, 2012, Properties of the adeno-associated virus assembly-activating protein, J Virol, 86, 13038, 10.1128/JVI.01675-12
Kawano, 2013, An experimental and computational evolution-based method to study a mode of co-evolution of overlapping open reading frames in the AAV2 viral genome, PLoS ONE, 8, e66211, 10.1371/journal.pone.0066211
Gao, 2003, Adeno-associated viruses undergo substantial evolution in primates during natural infections, Proc Natl Acad Sci U S A, 100, 6081, 10.1073/pnas.0937739100
Gao, 2004, Clades of Adeno-associated viruses are widely disseminated in human tissues, J Virol, 78, 6381, 10.1128/JVI.78.12.6381-6388.2004
Gao, 2005, New recombinant serotypes of AAV vectors, Curr Gene Ther, 5, 285, 10.2174/1566523054065057
Bello, 2009, Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues, Gene Ther, 16, 1320, 10.1038/gt.2009.82
Li, 2011, The fecal viral flora of California sea lions, J Virol, 85, 9909, 10.1128/JVI.05026-11
Li, 2010, Bat guano virome: predominance of dietary viruses from insects and plants plus novel mammalian viruses, J Virol, 84, 6955, 10.1128/JVI.00501-10
Farkas, 2004, A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus, J Gen Virol, 85, 555, 10.1099/vir.0.19616-0
Summerford, 1998, Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions, J Virol, 72, 1438, 10.1128/JVI.72.2.1438-1445.1998
Bell, 2011, The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice, J Clin Invest, 121, 2427, 10.1172/JCI57367
Shen, 2011, Terminal N-linked galactose is the primary receptor for adeno-associated virus 9, J Biol Chem, 286, 13532, 10.1074/jbc.M110.210922
Bell, 2012, Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid, J Virol, 86, 7326, 10.1128/JVI.00448-12
Shen, 2013, Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency, J Biol Chem, 288, 28814, 10.1074/jbc.M113.482380
Mietzsch, 2014, Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans, J Virol, 88, 2991, 10.1128/JVI.03371-13
Belyi, 2010, Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and circoviridae are more than 40 to 50 million years old, J Virol, 84, 12458, 10.1128/JVI.01789-10
Dutheil, 2014, Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter, J Virol, 10.1128/JVI.00412-14
Thomson, 1991, Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6, Nature, 351, 78, 10.1038/351078a0
Caselli, 2006, Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication, Virology, 346, 402, 10.1016/j.virol.2005.11.018
Caruso, 2009, U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis, Proc Natl Acad Sci U S A, 106, 20446, 10.1073/pnas.0905535106
Roossinck, 2011, The good viruses: viral mutualistic symbioses, Nat Rev Microbiol, 9, 99, 10.1038/nrmicro2491
Gurda, 2013, Capsid antibodies to different adeno-associated virus serotypes bind common regions, J Virol, 87, 9111, 10.1128/JVI.00622-13
Bartel, 2012, Directed evolution of novel adeno-associated viruses for therapeutic gene delivery, Gene Ther, 19, 694, 10.1038/gt.2012.20
Maheshri, 2006, Directed evolution of adeno-associated virus yields enhanced gene delivery vectors, Nat Biotechnol, 24, 198, 10.1038/nbt1182
Li, 2008, Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles, Mol Ther, 16, 1252, 10.1038/mt.2008.100
Koerber, 2008, DNA shuffling of adeno-associated virus yields functionally diverse viral progeny, Mol Ther, 16, 1703, 10.1038/mt.2008.167
Koerber, 2009, Molecular evolution of adeno-associated virus for enhanced glial gene delivery, Mol Ther, 17, 2088, 10.1038/mt.2009.184
Asuri, 2012, Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells, Mol Ther, 20, 329, 10.1038/mt.2011.255
Lisowski, 2014, Selection and evaluation of clinically relevant AAV variants in a xenograft liver model, Nature, 506, 382, 10.1038/nature12875
Dalkara, 2013, In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous, Sci Transl Med, 5, 189ra176, 10.1126/scitranslmed.3005708
Adachi, 2014, Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing, Nat Commun, 5, 3075, 10.1038/ncomms4075